Page 367 - 20dynamics of cancer
P. 367
352 REFERENCES
Cancer Incidence in Five Continents, Vol. VIII. International Agency for Re-
search on Cancer, Lyon, France.
Pelengaris, S., Khan, M., and Evan, G. 2002. c-MYC: more than just a matter of
life and death. Nature Reviews Cancer 2:764–776.
Peltomaki, P., and Vasen, H. F. 1997. Mutations predisposing to hereditary non-
polyposis colorectal cancer: database and results of a collaborative study.
The International Collaborative Group on Hereditary Nonpolyposis Colorec-
tal Cancer. Gastroenterology 113:1146–1158.
Peto, J. 2001. Cancer epidemiology in the last century and the next decade.
Nature 411:390–395.
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F.,
Evans, C., Deacon, J., and Stratton, M. R. 1999. Prevalence of BRCA1 and
BRCA2 gene mutations in patients with early-onset breast cancer. Journal of
the National Cancer Institute 91:943–949.
Peto, J., and Mack, T. M. 2000. High constant incidence in twins and other
relatives of women with breast cancer. Nature Genetics 26:411–414.
Peto, R. 1977. Epidemiology, multistage models and short-term mutagenicity
tests. In Hiatt, H. H., Watson, J. D., and Winsten, J. A., eds., Origins of Human
Cancer, pp. 1403–1428. Cold Spring Harbor Publications, New York.
Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., and Doll, R. 2000. Smok-
ing, smoking cessation, and lung cancer in the UK since 1950: combination
of national statistics with two case-control studies. British Medical Journal
321:323–329.
Peto, R., Gray, R., Brantom, P., and Grasso, P. 1991. Dose and time relation-
ships for tumor induction in the liver and esophagus of 4080 inbred rats
by chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethylamine.
Cancer Research 51:6452–6469.
Pfeifer, G. P., Steigerwald, S. D., Hansen, R. S., Gartler, S. M., and Riggs, A. D. 1990.
Polymerase chain reaction-aided genomic sequencing of an X chromosome-
linked CpG island: methylation patterns suggest clonal inheritance, CpG site
autonomy, and an explanation of activity state stability. Proceedings of the
National Academy of Sciences of the United States of America 87:8252–8256.
Pharoah, P. D., Antoniou, A., Bobrow, M., Zimmern, R. L., Easton, D. F., and Pon-
der, B. A. 2002. Polygenic susceptibility to breast cancer and implications for
prevention. Nature Genetics 31:33–36.
Pierce, D. A., and Vaeth, M. 2003. Age-time patterns of cancer to be anticipated
from exposure to general mutagens. Biostatistics 4:231–248.
Pike, M. C., Krailo, M. D., Henderson, B. E., Casagrande, J. T., and Hoel, D. G. 1983.
“Hormonal” risk factors, “breast tissue age” and the age-incidence of breast
cancer. Nature 303:767–770.
Pike, M. C., Pearce, C. L., and Wu, A. H. 2004. Prevention of cancers of the breast,
endometrium and ovary. Oncogene 23:6379–6391.
Platt, R. 1955. Clonal ageing and cancer. Lancet 265:867.